New bond issue: CSI Properties will issue international bonds for USD 200.0m

13 wrzesień 2017 - Cbonds

 

CSI Properties will issue international bonds for USD 200.0m. Bonds were sold at a price of 100%. Bookrunner: AMTD Asset Management Limited, China Merchants Bank, DBS Bank, HSBC, ICBC, JP Morgan, China Oceanwide Holdings, UBS
Depository: Euroclear Bank, Clearstream Banking S.A.
Udostępnij:
Emitent, numer emisjiCSI Properties, 5.75% perp., USD
Rodzaj instrumentu dłużnegoEuroobligacje
Status emisjiW obrocie
Typ rozmieszczeniaPubliczna
Nominał, waluta200.000 USD
Wartość emisji200 000 000
ISINXS1586438555
Zakończenie rozmieszczenia13.09.2017
Cena emisyjna100
Wysokość kuponu5.75% from the interest commencement 20.09.2022, 5Y UST Yield + 7.005% from 20.09.2022 to maturity
Częstotliwość wypłat kuponu2 raz(y) rocznie
Data, od której nalicza się oprocentowanie20.09.2017
Agent emisjiBookrunner: AMTD Asset Management Limited, China Merchants Bank, DBS Bank, HSBC, ICBC, JP Morgan, China Oceanwide Holdings, UBS Depository: Euroclear Bank, Clearstream Banking S.A.
Parkiet giełdowySGX
Emitent: CSI Properties
Profil emitenta:
CSI Properties Limited, an investment holding company, engages in property holding and leasing activities primarily in Hong Kong and the People’s Republic of China.
Obligacje w obrocie:
3 emisjiUSD600 000 000
minimizeexpand
150 000
issues: local and international bonds
170
countries
+7 812 336 97 21
pro@cbonds.info
150 000
issues: local and international bonds
170
countries
Сbonds is a global Fixed income data platform
+7 812 336 97 21
pro@cbonds.info
Data
  • Descriptive data on bonds
  • Bond Quotes from trading systems and market participants
  • Prospectuses and other issue documents
  • Credit ratings
  • Indices and indicators
  • Market news and analytical research
Analytical instruments
  • Multi-parameter bond database search
  • Bond Maps
  • Market calendar
  • Bond calculator
  • Watchlist and Portfolio management
  • Chart analysis
  • Mobile App and Excel Add-in Tool
Enter or RegisterSubscription/Trial access